Literature DB >> 9427713

Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex.

L A Trimble1, J Lieberman.   

Abstract

Although human immunodeficiency virus (HIV)-infected subjects without acquired immunodeficiency syndrome have a high frequency of HIV-specific CD8 T lymphocytes, freshly isolated lymphocytes frequently lack detectable HIV-specific cytotoxicity. However, this effector function becomes readily apparent after overnight culture. To investigate reasons for T-cell dysfunction, we analyzed T-cell expression of the cytolytic protease granzyme A and CD3 zeta, the signaling component of the T-cell receptor complex. An increased proportion of CD4 and CD8 T cells from HIV-infected donors contain granzyme A, consistent with the known increased frequency of activated T cells. In 28 HIV-infected donors with mild to advanced immunodeficiency, a substantial fraction of circulating T cells downmodulated CD3 zeta (fraction of T cells expressing CD3 zeta, 0.74 +/- 0.16 v 1.01 +/- 0.07 in healthy donors; P < .0000005). CD3 zeta expression is downregulated more severely in CD8 than CD4 T cells, decreases early in infection, and correlates with declining CD4 counts and disease stage. CD3 zeta expression increases over 6 to 16 hours of culture in an interleukin-2-dependent manner, coincident with restoration of viral-specific cytotoxicity. Impaired T-cell receptor signaling may help explain why HIV-specific cytotoxic T lymphocytes fail to control HIV replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427713

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  Profile of Judy Lieberman.

Authors:  Jennifer Viegas
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

3.  The functional CD8 T cell response to HIV becomes type-specific in progressive disease.

Authors:  Sang Kyung Lee; Zhan Xu; Judy Lieberman; Premlata Shankar
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

5.  Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV).

Authors:  Lesley White; Subramaniam Krishnan; Natasa Strbo; Huanliang Liu; Michael A Kolber; Mathias G Lichtenheld; Rajendra N Pahwa; Savita Pahwa
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

6.  HIV-induced changes in T cell signaling pathways.

Authors:  Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

Authors:  Edwin Leeansyah; Jingling Zhou; Geza Paukovics; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

8.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.

Authors:  M Nedim Ince; Brooke Harnisch; Zhan Xu; Sang-Kyung Lee; Christoph Lange; Lorenzo Moretta; Michael Lederman; Judy Lieberman
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection.

Authors:  T U Vogel; T M Allen; J D Altman; D I Watkins
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.